What is the recommended dosage for intravenous (IV) Nitroglycerin (NTG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage for Intravenous (IV) Nitroglycerin

Intravenous nitroglycerin should be initiated at 5 mcg/min through non-absorbing tubing and titrated up by 5 mcg/min every 3-5 minutes until symptom relief or blood pressure response is observed. 1, 2

Initial Preparation and Administration

  • IV nitroglycerin must be diluted prior to infusion:

    • Standard dilution: 50 mg in 500 mL D5W or NS (100 mcg/mL)
    • Alternative dilution: 5 mg in 100 mL (50 mcg/mL)
    • Maximum concentration should not exceed 400 mcg/mL 1
  • Use non-absorbing tubing (critical for accurate dosing)

    • PVC tubing absorbs nitroglycerin, requiring higher doses
    • Non-absorbing tubing requires lower doses 1

Dosing Algorithm

  1. Starting dose: 5 mcg/min when using non-absorbing tubing 2, 1
  2. Initial titration:
    • Increase by 5 mcg/min every 3-5 minutes until response is noted
    • If no response at 20 mcg/min, increase by 10 mcg/min increments
    • If still no response, increase by 20 mcg/min increments 2, 1
  3. After partial response:
    • Reduce increment size
    • Lengthen interval between increases 1
  4. Maintenance: Continue at effective dose; may require periodic increases if used beyond 24 hours due to tolerance 2

Maximum Dosage

  • Common ceiling: 200 mcg/min 2
  • Higher doses (300-400 mcg/min) have been used for prolonged therapy without increasing methemoglobin levels 2
  • Ultra-high doses (up to several mg) have been reported in severe cases of Sympathetic Crashing Acute Pulmonary Edema (SCAPE) 3

Monitoring Parameters

  • Blood pressure and heart rate
  • Clinical symptoms
  • Watch for hypotension (SBP <90 mmHg or 30 mmHg below baseline)
  • Monitor for reflex tachycardia which can worsen myocardial ischemia 4

Important Contraindications and Precautions

  • Absolute contraindication: Use of phosphodiesterase-5 inhibitors
    • Sildenafil within previous 24 hours
    • Tadalafil within previous 48 hours
    • Vardenafil (timing not established, but at least 24 hours) 2, 4
  • Relative contraindications:
    • Systolic BP <90 mmHg
    • Right ventricular infarction
    • Severe aortic stenosis 4

Special Considerations

  • Hypersensitivity: Some patients (especially those with normal/low LV filling pressures) may respond fully to doses as low as 5 mcg/min 1
  • Tolerance: Develops after 24 hours of continuous therapy; may require dose increases to maintain efficacy 2
  • For prolonged therapy: Consider nitrate-free intervals of 10-14 hours to prevent tolerance 4

Clinical Pearls

  • Flush or replace the infusion set when changing concentration to avoid delayed dose delivery 1
  • For patients with refractory chest pain despite sublingual NTG, IV NTG is recommended in the absence of contraindications 2
  • If chest pain persists despite IV NTG, consider adding morphine sulfate (1-5 mg IV) with careful blood pressure monitoring 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute and Chronic Angina Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.